News

Featured News

  • 2024 |
  • 2023 |
  • 2022 |
  • 2021 |
  • 2020 |
  • 2019 |
  • 2018 |
  • 2017 |
  • View All
  • Press Release | December 14, 2023

    First In Vivo CAR-M Lead Candidate Nominated Under Carisma-Moderna Collaboration

    Read More

    Press Release | December 7, 2023

    Vittoria Biotherapeutics Announces FDA Clearance of IND Application for VIPER-101 to Treat T-Cell Lymphoma

    Read More

    Press Release | December 5, 2023

    Dragonfly Therapeutics Initiates Phase 1/1b Study of its IL-2 Immunotherapy in Patients with Advanced Solid Tumors

    Read More

    Press Release | November 28, 2023

    Carisma Therapeutics Announces FDA Clearance of IND Application for CT-0525, a Novel HER2-Targeting CAR-Monocyte

    Read More

    Press Release | November 20, 2023

    Cantai Therapeutics is Co-Founded by Agent Capital and 82VS to Advance Next-Generation Bispecific Antibodies for Autoimmune Diseases

    Read More

    News | October 25, 2023

    A new era in medicine: unraveling the evolution and future of gene therapy

    Read More

    News | October 23, 2023

    Skyhawk Therapeutics Receives HREC Approval for a Phase 1 Study of its SKY-0515 RNA-Targeting Small Molecule for Huntington’s Disease

    Read More

    News | October 19, 2023

    Flare Therapeutics Announces First Patients Dosed in First-in-Human Phase 1 Clinical Study of FX-909 in Advanced Solid Malignancies, Including Urothelial Cancer

    Read More

    News | October 16, 2023

    ImCheck to Present New Positive Data on ICT01 Monotherapy in Hematological Cancers at ESMO 2023

    Read More

    Press Release | October 5, 2023

    Kyowa Kirin to Acquire Orchard Therapeutics

    Read More

    Press Release | September 26, 2023

    Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from Phase 2a INTEGRIS-PSC Clinical Trial of Bexotegrast in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis

    Read More

    Press Release | September 21, 2023

    Entrada Therapeutics Announces First Participant Dosed in its Phase 1 Clinical Trial of ENTR-601-44 for the Potential Treatment of Duchenne Muscular Dystrophy

    Read More

    News | September 20, 2023

    ImCheck has been short-listed among the top 10 “Biotech et Medtech” companies for the 2023 edition of Les Trophées des Futures Licornes, which rewards the growth potential of innovative French companies.

    Read More

    Press Release | September 5, 2023

    Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb

    Read More

    Press Release | September 5, 2023

    Star Therapeutics raises $90 million financing to accelerate its pipeline of novel antibody therapies and growth of its portfolio companies

    Read More

    News | August 25, 2023

    Investing long-term in the cell & gene therapies of the future (Podcast with Geeta Vemuri and David McCall)

    Read More

    Press Release | August 23, 2023

    Pyxis Oncology Successfully Completes Acquisition of Apexigen

    Read More

    News | August 17, 2023

    Patent Awarded for Primary Template-Directed Amplification, Further Strengthening BioSkryb Genomics’ Core Technologies

    Read More

    Press Release | August 15, 2023

    Precision BioSciences Completes Strategic Transaction with Imugene for Azer-Cel in Cancer

    Read More

    Press Release | August 3, 2023

    Orchard Therapeutics Completes Submission of Biologics License Application for OTL-200 in MLD to U.S. FDA

    Read More